News

A new push by doctors and researchers last week on a Food and Drug Administration panel pushed the agency to remove what they ...
Hormone therapies for menopause have come with black box warnings for decades. Our wellness expert explains why this could ...
A Food and Drug Administration (FDA) expert panel has reignited a debate over whether hormone therapy should be used to treat ...
A panel selected by FDA Commissioner Marty Makary, MD, MPH, unanimously urged the agency to remove the boxed warning on ...
On Thursday in Washington, D.C., the U.S. Food and Drug Administration (FDA) convened a panel of top experts to reassess the ...
Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated ...
The contrast between the FDA’s clinical lens and the raw realities in the Bonafide study highlights a critical disconnect ...
Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with menopause hormone therapy. A Mayo Clinic study revealed that this dual ...
“The role of testosterone is just a lesson in gender bias,” says Kelly Casperson, MD, a urologist. “Because 100 percent of ...
Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.
SAN FRANCISCO -- Menopause hormone therapy (MHT) was tied to a weight-loss boost in postmenopausal women taking a weight loss ...